In last trading session, Aspire Biopharma Holdings Inc (NASDAQ:ASBP) saw 0.35 million shares changing hands with its beta currently measuring 0.86. Company’s recent per share price level of $0.45 trading at -$0.09 or -16.46% at ring of the bell on the day assigns it a market valuation of $20.76M. That closing price of ASBP’s stock is at a discount of -3411.11% from its 52-week high price of $15.80 and is indicating a discount of -15.56% from its 52-week low price of $0.52. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.17 million shares which gives us an average trading volume of 528.49K if we extend that period to 3-months.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP) trade information

Upright in the red during last session for losing -16.46%, in the last five days ASBP remained trading in the red while hitting it’s week-highest on Wednesday, 04/02/25 when the stock touched $0.45 price level, adding 27.88% to its value on the day. Aspire Biopharma Holdings Inc’s shares saw a change of -96.08% in year-to-date performance and have moved -29.51% in past 5-day. Aspire Biopharma Holdings Inc (NASDAQ:ASBP) showed a performance of -47.54% in past 30-days. Number of shares sold short was 47452.0 shares which calculate 0.09 days to cover the short interests.

Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s Major holders

Insiders are in possession of 25.27% of company’s total shares while institution are holding 1.03 percent of that, with stock having share float percentage of 1.37%. Investors also watch the number of corporate investors in a company very closely, which is 1.03% institutions for Aspire Biopharma Holdings Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund and Tidal ETF Trust-Robinson Alternative Yield Pre-Merger SPAC ETF are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 5.29 shares of worth $2385.0 or 0.07% of the total outstanding shares. The later fund manager was in possession of 2.88 shares on Jan 31, 2025 , making its stake of worth around $1299.0 in the company or a holder of 0.04% of company’s stock.